Skip to main content

Table 2 Baseline characteristics of neonates according to their mothers’ thyroid status

From: Evaluation of the impact of levothyroxine treatment on the psychomotor developmental status of three-year-old children born to mothers with mild thyroid impairment; Tehran Thyroid and pregnancy study: study protocol for a randomized clinical trial

Characteristics

SCH-TPOAb−

SCH-TPOAb+

 

LT4 treatment

(n = 183)

Placebo

(n = 183)

LT4 treatment

(n = 65)

Placebo

(n = 66)

Euthyroid TPOAb− (n = 1028)

Gestational age, mean (SD)

38.03 (1.4)

37.9 (1.5)

39.3 (1.3)

38.4 (1.7)

39.4 (1.4)

Birth weight, mean (SD)

3190.82 (455.13)

3203.1 (497.1)

3139.1 (287.6)

3127.7 (523.5)

3236.6 (448.8)

Birth height, mean (SD)

50.1 (2.3)

50.2 (2.7)

49.5 (1.7)

50.3 (1.5)

50.1 (2.3)

Birth head circumference, mean (SD)

34.6 (1.4)

34.7 (1.6)

34.5(1.1)

34.9 (1.4)

34.7 (2.3)

TSH (μIU/mL), Median (IQ)

1.1 (0.5–2.1)

1.1 (0.5–1.9)

1.3 (0.45–1.9)

1.0 (.43–1.9)

0.90 (0.4–1.7)

  1. SCH subclinical hypothyroidism, TPOAb thyroid peroxidase antibodies, TSH thyroid-stimulating hormone, LT4 levothyroxine